Abstract
Oligopeptides are generally thought to have poor permeability across biological membranes. Recent studies, however, suggest significant distribution of [Dmt1]DALDA (Dmt-d-Arg-Phe-Lys-NH2; Dmt is 2′,6′-dimethyltyrosine), a 3+ net charge opioid peptide, to the brain and spinal cord after subcutaneous administration. Peptide transporters (PEPT1 and PEPT2) play a major role in the uptake of di- and tripeptides across cell membranes, but their ability to transport tetrapeptides is not clear. The purpose of this study was to determine whether [Dmt1]DALDA can translocate across Caco-2 cell monolayers and whether PEPT1 plays a role in the uptake process. Our results show that [3H][Dmt1]DALDA can readily translocate across Caco-2 cells, with a permeability coefficient estimated to be 1.24 × 10−5 cm/s. When incubated with Caco-2 cells, [3H][Dmt1]DALDA was detected in cell lysates by 5 min. The internalization of [Dmt1]DALDA was confirmed visually with a fluorescent [Dmt1]DALDA analog (H-Dmt-d-Arg-Phe-dnsDap-NH2; dnsDap is β-dansyl-l-α,β-diaminopropionic acid). The uptake of [3H][Dmt1]DALDA was concentration-dependent but temperature- and pH-independent. Treatment with diethylpyrocarbonate (DEPC) inhibited [14C]glycine-sarcosine uptake but increased [3H][Dmt1]DALDA uptake 34-fold. These findings suggest that PEPT1 is not involved in [Dmt1]DALDA internalization. [Dmt1]DALDA uptake was also observed in SH-SY5Y, human embryonic kidney 293, and CRFK cells, and was independent of whether the cells expressed opioid receptors. The efflux of [3H][Dmt1]DALDA from Caco-2 cells was temperature-dependent and was inhibited by DEPC, but was not affected by verapamil, an inhibitor of P-glycoprotein. These data show transcellular translocation of a highly polar 3+ charge tetrapeptide and suggest that [Dmt1]DALDA may not only distribute across the blood-brain barrier but also it may even have reasonable oral absorption.
Footnotes
-
This work was supported, in part, by a Multi-Center Program Project Grant (PO1 DA08924) from the National Institute on Drug Abuse.
-
DOI: 10.1124/jpet.102.040147
- Abbreviations:
- [Dmt1]DALDA
- H-Dmt-d-Arg-Phe-Lys-NH2, where Dmt is 2′,6′-dimethyltyrosine
- PEPT
- peptide transporter
- Gly-Sar
- glycine-sarcosine
- MEM
- minimal essential medium
- HEK
- human embryonic kidney
- HBSS
- Hanks' balanced salt solution
- CLSM
- confocal laser scanning microscopy
- [Dmt1,dnsDap4]DALDA
- H-Dmt-d-Arg-Phe-dnsDap-NH2, where dnsDap is β-dansyl-l-α,β-diaminopropionic acid
- PBS
- phosphate-buffered saline
- DEPC
- diethylpyrocarbonate
- Papp
- apparent permeability coefficient
- Received June 7, 2002.
- Accepted September 11, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|